Q32 Bio Inc. (QTTB) Financials

QTTB Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 115.9 million 10.0 million
March 31, 2026 63.7 million 17.4 million
Dec. 31, 2025 61.8 million 19.8 million
Sept. 30, 2025 57.8 million 76.2 million

QTTB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.1 million 1.7 million
March 31, 2026 -6.3 million 1.5 million
Dec. 31, 2025 -6.2 million 1.5 million
Sept. 30, 2025 -4.2 million 1.2 million

QTTB Net Income

No data available :(

QTTB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 106.3 million 4.6 million 4.6 million
March 31, 2026 50.8 million 1.9 million 4.8 million
Dec. 31, 2025 48.3 million 3.5 million 4.9 million
Sept. 30, 2025 49.0 million 5.0 million 5.8 million

QTTB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 20.3 million
March 31, 2026 14.1 million
Dec. 31, 2025 13.2 million
Sept. 30, 2025 12.2 million

QTTB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 4.3 million 4.9 million -
March 31, 2026 - 3.2 million 4.5 million -
Dec. 31, 2025 - 3.3 million 4.5 million -
Sept. 30, 2025 - 3.6 million 4.0 million -

QTTB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 90000
Dec. 31, 2025 53.7 million 90000
Sept. 30, 2025 - 91000

QTTB

Price: $15.86

52 week price:
1.57
23.57

Earnings Per Share: 3.14 USD

P/E Ratio: 4.91

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 458.7 million

Links: